Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Condition(s):Acute Heart FailureLast Updated:March 7, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Heart FailureLast Updated:March 7, 2024Recruiting
Condition(s):Non-squamous Non-small-cell Lung Cancer; EGFR Activating MutationLast Updated:October 4, 2023Active, not recruiting
Condition(s):Living-donor Liver TransplantationLast Updated:March 28, 2024Active, not recruiting
Condition(s):Schizophrenia RelapseLast Updated:September 9, 2021Completed
Condition(s):Lung CancerLast Updated:April 5, 2022Active, not recruiting
Condition(s):Coronary Artery DiseaseLast Updated:May 17, 2021Completed
Condition(s):Hypertension; Coronary AtherosclerosisLast Updated:May 14, 2021Completed
Condition(s):Coronary Disease; HypercholesterolemiaLast Updated:October 4, 2023Completed
Condition(s):Cardiovascular DiseaseLast Updated:August 30, 2021Terminated
Condition(s):ICULast Updated:October 31, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.